Beta-blockers and atrial natriuretic peptide (ANP) in hypertension

International Journal of Immunopathology and Pharmacology

Volumn 13, Issue 2, 2000, Pages 107-110

  Papadopoulos, C L ^a,b   Kokkas, B A ^a   Anogiannakis, G A ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

Arterial hypertension; Atrial natriuretic peptides; Beta adrenergic blockers

Indexed keywords

ATENOLOL; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BISOPROLOL; CELIPROLOL; METOPROLOL;

HORMONE RELEASE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; PRIORITY JOURNAL; SHORT SURVEY; VASCULAR RESISTANCE;

EID: 0033867770     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (26)

1. Lang R.E., H. Tholken, D. Ganten, F. Luft, H. Ruskoanho and T. Unger. 1985. Atrial natriuretic factor: a circulating hormone stimulated by volume loading factor. Nature 314: 264.
2. Sagnella G.A., N.M. Mardanda, A.C. Shore and G.A. MacGragor. 1985. Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet II: 1208.
3. Sagawara A., K. Nakao, M. SakamotoN. Morii, T. Yamada, H. Itoh, S. Shiono and H. Umura. 1985. Plasma concentration of atrial natriuretic polypeptide in essential hypertension. Lancet II: 1426.
4. Sagnella G.A., N.D. Markanda, A.C. Shore and G.A. MacGregor. 1986. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1:179.
5. Racz K., O. Kuckel, N.T. Buu, W. Debinski, M. Cantin and J. Genest. 1986. Atrial natriuretic factor, catecholamines, and natriuresis. N. Engl. J. Med. 314: 312.
6. Raine A.E.G., P. Erne, E. Burgisser, F. Muller, P. Bolli, F. Burkart and F. Buhler. 1986. Atrial natriuretic factor and atrial pressure in patients with congestive heart failure. N. Engl. J. Med. 315:533.
7. Kohno M., K.B. Clegg and M.P. Sambhi. 1987. Effects of volume change on circulating immunoreactive atrial natriuretic factor in rat. Hypertension 10: 171.
8. Atlas S.A. and J.H. Laragh. 1990. In Atrial natriuretic factor and its involvement in hypertensive disorders. Laragh JH, Brenner BM ed. Hypertension, Raven Press, New York, p. 861-833.
9. Lewicki J.A. and A.A. Protter. 1995. In Physiological studies of the natriuretic peptide family. Laragh JH, Brenner BM (eds). Hypertension, 2nd ed., Raven Press, New York, p. 1029.
10. Consolo F., P. Monardo and P. Consolo. 1998. Influence of Losartan therapy on tubular sodium kinetics in mild to moderate hypertension. Int. J. Immunopathol. Pharmacol. 11:101
11. Kokkas B., C. Papadopoulos, M. Mironidou, M. Kotoula, A. Kouyoumtzis, I. Kanonodis, C. Voulgaropoulos and V. Mirtsou. 1999. Comparison of felodipine and nitroglycerin actions onvasomotion physiology. Int. J. Immunopathol. Pharmacol. 12:37
12. Matsubara H., Y. Hirata, H. Yoshimi, S. Takata, Y. Takagi, Y. Umeda, Y. Yamane and M. Inada . 1988. Role of calcium and protein kinase C in ANP secretion be cultured rat cardiocytes. Am. J. Physiol. H405.
13. Shields P.P. and C.C. Glembotski. 1989. Regulation of atrial natriuretic factor-secretion from neonatal rat primary atrial cultures by activators of protein kinases A and C. J. Biol. Chem. 264:9322.
14. Hollenbeck M., J. Plum, P. Hearing, B. Kutkuhn and B. Grabensee. 1991. Influence of betaxolol on renal function and atrial natriuretic peptide in essential hypertension. J. Hypertens. 9:819.
15. Hanna J., S. Nagata, T. Takenaka, H. Kino, S. Shimada, M. Horiuchi and R. Katori. 1995. Atrial natriuretic peptide and antihypertensive action due to beta-blockade in essential hypertensive patients. Angiology 46:511.
16. Papadopoulos C.L., B.A. Kokkas, P.S. Kotridis, C. Th. Gitsios, G.C. Sakadamis, J.E. Kanonidis, M.I. Kotoula and A.G. Paradelis. 1995. The Effect of β1-Blocker Bisoprolol on Atrial Natriuretic Peptide Plasma Levels in Hypertensive Patients. Intern. J. Angiol. 4:165.
17. Papadopoulos C., B. Kokkas, P. Kotridis and M. Caramouzis. The effect of β1-blocker/β2-agonist celiprolol on atrial natriouretic peptide in arterial hypertension. Unpublished yet data.
18. Geller D., M. Currie, K. Wakitani, B. Cole, S. Adams, K. Fok, N. Siegel, S. Eubanks, G. Galluppi and P. Needeeman. 1984. Atriopeptines. Bioch. Biophy Res. Com. 120:333.
19. Guyton A.C., J.E. Gall, T.G. Coleman and R.D. Manning. 1990. In: The dominant role of the kidneys in the long-term regulation of arterial pressure in normal and hypertensive states. Laragh JH and Brenner BM ed. Hypertension, Raven Press, New York, p. 1029.
20. London G.M., J. A. Levenson and A.M. London. 1984. Renal and systolic hemodynamics in sustained essential hypertension. Hypertension 6:743.
21. Path M., C. Steimer, J.L. Cazor and J. Schwartz. 1983. Study of the dose response of betaxolol in arterial hypertension. Therapie 38: 143.
22. Hanssen W.M.T., D. DeZeeuw, G. Van der Hem and P.E. De Jong. 1989. Antihypertensive effect of a 5 day infusion of atrial natriuretic factor in humans. Hypertension 13:640.
23. Struyker-Boudier H.A.J. and J.F.M. Smits. 1989. Antihypertensive action of beta-adrenoreceptor blocking drugs. Am. J. Hypertens. 2:237S.
24. Epstein M. and J.R. Oster. 1982. Beta-blockers and the kidney. Miner Electolyte Metab. 8:237.
25. Sonotani N., S. Kubo, A. Nishioka and T. Takatsu. 1981. Electrocardiographic and echocardiographic changes after one to two-years treatment of hypertension. Jpn. Heart J. 22:325.
26. Geller D., M. Currie, K. Wakitani, B. Cole, S. Adams, K. Fok, N. Siegel, S. Eubanks, G. Galluppi and P. Needeeman. 1984. Atriopeptines. Bioch. Biophys. Res. Com. 120:333.